Nisa Investment Advisors’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-79
| Closed | -$2.68K | – | 3106 |
|
|
2025
Q4 | $2.68K | Hold |
79
| – | – | ﹤0.01% | 2564 |
|
|
2025
Q3 | $2.04K | Hold |
79
| – | – | ﹤0.01% | 2613 |
|
|
2025
Q2 | $632 | Sell |
79
-35
| -31% | -$267 | ﹤0.01% | 2833 |
|
|
2025
Q1 | $1.11K | Buy |
114
+47
| +70% | +$462 | ﹤0.01% | 2612 |
|
|
2024
Q4 | $842 | Buy |
+67
| New | +$851 | ﹤0.01% | 2715 |
|
|
2024
Q3 | – | Sell |
-5
| Closed | -$119 | – | 3028 |
|
|
2024
Q2 | $119 | Buy |
5
+2
| +67% | +$92 | ﹤0.01% | 2866 |
|
|
2024
Q1 | $180 | Buy |
3
+2
| +200% | +$278 | ﹤0.01% | 2659 |
|
|
2023
Q4 | $224 | Sell |
1
-2
| -67% | -$248 | ﹤0.01% | 2535 |
|
|
2023
Q3 | $399 | Buy |
3
+1
| +50% | +$163 | ﹤0.01% | 2560 |
|
|
2023
Q2 | $337 | Hold |
2
| – | – | ﹤0.01% | 2640 |
|
|
2023
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 2667 |
|
|
2022
Q4 | $0 | Sell |
2
-1
| -33% | -$160 | ﹤0.01% | 2687 |
|
|
2022
Q3 | $1K | Buy |
+3
| New | +$567 | ﹤0.01% | 2490 |
|
|
2020
Q4 | – | Sell |
-41
| Closed | -$11K | – | 2337 |
|
|
2020
Q3 | $11K | Hold |
41
| – | – | ﹤0.01% | 2107 |
|
|
2020
Q2 | $10K | Buy |
41
+23
| +128% | +$3.56K | ﹤0.01% | 1923 |
|
|
2020
Q1 | $3K | Buy |
+18
| New | +$4.1K | ﹤0.01% | 2013 |
|
Nisa Investment Advisors's RAPT Position: Q1 2026 in Review
Nisa Investment Advisors sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 79 shares — an estimated $2.68K sold.
Nisa Investment Advisors first reported a position in RAPT in Q1 2020 and held it in 16 quarters. The position peaked at $11K in Q3 2020. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.
- Nisa Investment Advisors reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
- Nisa Investment Advisors sold 79 RAPT Therapeutics shares in Q1 2026, an estimated $2.68K.
- Nisa Investment Advisors first reported a position in RAPT Therapeutics in Q1 2020 and held it in 16 quarters.
- Nisa Investment Advisors's RAPT Therapeutics position peaked at $11K in Q3 2020.
- 0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.
Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.